MEDLINX Limited Liability Company
AS208411 is MEDLINX Limited Liability Company (medlinx.online). It announces 1,024 IPv4 addresses in 5 prefixes, and 1 IPv6 prefixes.
Russia· RIPE· allocated 2019-08-08· business
Where its space is
The IPv4 it announces that IP Geolocation places, by country. A /24 counts for the AS announcing most of it.
- Russia1,024 · 100.00%
Registry record
Its ASN Whois record, as the registry publishes it.
- handle
- MEDLINX-AS
- name
- MEDLINX Limited Liability Company
- org
- ORG-MLLC3-RIPE
- org name
- MEDLINX Limited Liability Company
- org address
- Academica Pavlova st.5, 197022, St.Petersburg, RUSSIAN FEDERATION
- org country
- RU
- country
- RU
- source
- ripe
- status
- ASSIGNED
- created
- 2019-08-08
- updated
- 2025-02-28
- maintainer
- RIPE-NCC-END-MNT|mnt-ru-medlinx-1
- abuse name
- Abuse-C Role
- abuse email
- it-services@medlinx.online
- abuse kind
- role
What the databases see
Addresses each address-keyed database holds in the IPv4 it announces, as a share of that space, with its largest providers. Counts overlap.
- 0.39%
- None here
- None here
- None here
- None here
- None here
- Hosting IP25625.00%
- None here
- None here
- None here
- 0.49%
- 0.10%
- 0.20%
IPv4 prefixes
Every IPv4 prefix BGP Route saw it announce. A prefix another AS also announces says so.
| PREFIX | COUNTRY | RPKI | PEERS | FIRST SEEN |
|---|---|---|---|---|
| 45.137.252.0/22 | Russia | valid | 17 | 2026-10-02 |
| 45.137.252.0/24 | Russia | valid | 17 | 2026-10-02 |
| 45.137.253.0/24 | Russia | valid | 17 | 2026-10-02 |
| 45.137.254.0/24 | Russia | valid | 17 | 2026-10-02 |
| 45.137.255.0/24 | Russia | valid | 17 | 2026-10-02 |
IPv6 prefixes
Every IPv6 prefix BGP Route saw it announce.
| PREFIX | COUNTRY | RPKI | PEERS | FIRST SEEN |
|---|---|---|---|---|
| 2a0e:b2c0::/30 | Russia | valid | 20 | 2026-10-02 |
Test the real build first.
An evaluation license puts a full current build in your hands — every row, every column, no sampling — so you can measure it against your own traffic before anyone talks about terms.